resveratrol has been researched along with Chronic Kidney Diseases in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 8 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, C; He, W; Huang, X; Qiu, Y; Shi, Q; Sun, D; Wang, Y; Yang, J | 1 |
| Gong, H; Huang, X; Li, L; Lu, F; Wang, R; Yuan, W; Zhang, L | 1 |
| Aly, RG; Basta, M; Dief, AE; Saleh, SR | 1 |
| Chang, CI; Chang-Chien, GP; Hou, CY; Hsu, CN; Lin, S; Tain, YL | 1 |
| Chen, K; Chen, X; Guo, N; Huang, X; Li, P; Liu, Y; Song, X; Wu, C; Yuan, L; Zhang, D | 1 |
| de Alba Macías, LA; Fuentes Preciado, AR; Martínez Garza, S; Murillo Ortiz, BO; Ramírez Emiliano, J; Ramos Rodríguez, E | 1 |
| Assefa, EG; Gezahegn, SB; He, S; Salissou, MTM; Wu, N; Yan, Q; Ying, C; Zuo, X | 1 |
| Chang, JF; Chen, BH; Chen, PJ; Hou, YC; Liu, WC; Lu, CL; Lu, KC; Shen, TC; Song, JY; Zheng, CM | 1 |
| Chen, PH; Chiu, HW; Hou, YC; Lim, PS; Lin, YF; Liu, WC; Lu, CL; Lu, KC; Shyu, JF; Zheng, CM | 1 |
| Alirezaei, A; Asgharpour, M | 1 |
| Chen, SJ; Jiang, GR; Liu, S; Sun, LJ; Sun, YN | 1 |
| Han, Y; Hui, Y; Jin, R; Li, L; Liu, W; Lu, M; Zhou, H | 1 |
| Chen, YJ; Cheng, FY; Chiu, HW; Hsu, YH; Lee, YH; Lin, YF | 1 |
| Ban, TH; Chang, YS; Choi, BS; Jang, IA; Kim, EN; Kim, MY; Lim, JH; Park, CW; Yoon, HE | 1 |
| Chen, J; Guan, Y; Hao, CM; Huang, XZ; Ma, L; Ren, Y; Wen, D; Xie, Q; Zhang, M | 1 |
| Carraro-Eduardo, JC; Leal, Vde O; Mafra, D; Saldanha, JF; Stenvinkel, P | 1 |
| Carraro-Eduardo, JC; Daleprane, JB; Grimmer, GH; Leal, VO; Mafra, D; Ribeiro-Alves, M; Rizzetto, F; Saldanha, JF | 1 |
| Chander, V; Chopra, K | 1 |
3 review(s) available for resveratrol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Influence of Resveratrol on the Cardiovascular Health Effects of Chronic Kidney Disease.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Humans; Renal Insufficiency, Chronic; Resveratrol; Risk Factors | 2020 |
Herbal antioxidants in dialysis patients: a review of potential mechanisms and medical implications.
Topics: Antioxidants; Cardiovascular Diseases; Curcumin; Emodin; Humans; Inflammation; Oxidative Stress; Plant Extracts; Quercetin; Renal Dialysis; Renal Insufficiency, Chronic; Resveratrol; Silymarin | 2021 |
Resveratrol: why is it a promising therapy for chronic kidney disease patients?
Topics: Humans; Inflammation; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Multiprotein Complexes; Oxidative Stress; Renal Insufficiency, Chronic; Resveratrol; Stilbenes; TOR Serine-Threonine Kinases | 2013 |
2 trial(s) available for resveratrol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Recovery Of Bone And Muscle Mass In Patients With Chronic Kidney Disease And Iron Overload On Hemodialysis And Taking Combined Supplementation With Curcumin And Resveratrol.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Bone Density; Curcumin; Dietary Supplements; Double-Blind Method; Female; Ferritins; Humans; Iron Overload; Male; Middle Aged; Muscles; Renal Dialysis; Renal Insufficiency, Chronic; Resveratrol; Triglycerides | 2019 |
Effects of Resveratrol Supplementation in Nrf2 and NF-κB Expressions in Nondialyzed Chronic Kidney Disease Patients: A Randomized, Double-Blind, Placebo-Controlled, Crossover Clinical Trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Double-Blind Method; Female; Humans; Leukocytes, Mononuclear; Male; Middle Aged; NF-E2-Related Factor 2; NF-kappa B; Pilot Projects; Renal Insufficiency, Chronic; Resveratrol; Stilbenes | 2016 |
13 other study(ies) available for resveratrol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Resveratrol ameliorates high-phosphate-induced VSMCs to osteoblast-like cells transdifferentiation and arterial medial calcification in CKD through regulating Wnt/β-catenin signaling.
Topics: Animals; beta Catenin; Cell Transdifferentiation; Cells, Cultured; Core Binding Factor Alpha 1 Subunit; Humans; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Osteoblasts; Phosphates; Rats; Renal Insufficiency, Chronic; Resveratrol; Vascular Calcification; Wnt Proteins | 2022 |
Resveratrol ameliorates muscle atrophy in chronic kidney disease via the axis of SIRT1/FoxO1.
Topics: Animals; Forkhead Box Protein O1; Mice; Muscular Atrophy; Nerve Tissue Proteins; Rats; Renal Insufficiency, Chronic; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes | 2022 |
Resveratrol ameliorates the behavioural and molecular changes in rats exposed to uninephrectomy: role of hippocampal SIRT1, BDNF and AChE.
Topics: Animals; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Hippocampus; Male; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Resveratrol; Sirtuin 1; Stilbenes | 2023 |
Dietary Resveratrol Butyrate Monoester Supplement Improves Hypertension and Kidney Dysfunction in a Young Rat Chronic Kidney Disease Model.
Topics: Adenine; Animals; Butyrates; Dietary Supplements; Hypertension; Kidney; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Resveratrol | 2023 |
Resveratrol improves left ventricular remodeling in chronic kidney disease via Sirt1-mediated regulation of FoxO1 activity and MnSOD expression.
Topics: Animals; Antioxidants; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Resveratrol; Sirtuin 1; Superoxide Dismutase; Ventricular Remodeling | 2020 |
Role of Resveratrol on Indoxyl Sulfate-Induced Endothelial Hyperpermeability via Aryl Hydrocarbon Receptor (AHR)/Src-Dependent Pathway.
Topics: Animals; Antigens, CD; Antioxidants; Aorta; Atherosclerosis; Cadherins; Cattle; Cell Membrane Permeability; Cells, Cultured; Electric Impedance; Endothelial Cells; Indican; Oxidative Stress; Receptors, Aryl Hydrocarbon; Renal Insufficiency, Chronic; Resveratrol; Signal Transduction; src-Family Kinases | 2019 |
Resveratrol Rescue Indoxyl Sulfate-Induced Deterioration of Osteoblastogenesis via the Aryl Hydrocarbon Receptor /MAPK Pathway.
Topics: Animals; Bone and Bones; Cell Differentiation; Humans; Indican; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Models, Biological; Osteoblasts; Osteogenesis; Phosphorylation; Protective Agents; Receptors, Aryl Hydrocarbon; Renal Insufficiency, Chronic; Resveratrol; Signal Transduction | 2020 |
Resveratrol attenuates skeletal muscle atrophy induced by chronic kidney disease via MuRF1 signaling pathway.
Topics: Animals; Dose-Response Relationship, Drug; Mice; Mice, Inbred C57BL; Muscle Proteins; Muscular Atrophy; NF-kappa B; Renal Insufficiency, Chronic; Resveratrol; Signal Transduction; Stilbenes; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2017 |
Resveratrol improves mitochondrial function in the remnant kidney from 5/6 nephrectomized rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cell Line; Disease Models, Animal; Gene Expression Regulation; Kidney; Male; Mice; Mitochondria; Nephrectomy; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Resveratrol; Stilbenes | 2017 |
Resveratrol-loaded nanoparticles conjugated with kidney injury molecule-1 as a drug delivery system for potential use in chronic kidney disease.
Topics: Animals; Antibodies; Autophagy; Cell Line; Cell Survival; Creatinine; Drug Carriers; Drug Liberation; Epithelial Cells; Hepatitis A Virus Cellular Receptor 1; Humans; Inflammasomes; Interleukin-1beta; Kidney Tubules; Lactic Acid; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Nephritis, Interstitial; NLR Family, Pyrin Domain-Containing 3 Protein; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Renal Insufficiency, Chronic; Resveratrol; Stilbenes | 2017 |
Effects of Resveratrol on the Renin-Angiotensin System in the Aging Kidney.
Topics: Albuminuria; Angiotensin I; Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Collagen Type IV; Fibronectins; Fibrosis; Kidney; Male; Mice, Inbred C57BL; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Peptide Fragments; Plant Extracts; Proto-Oncogene Proteins; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Renal Insufficiency, Chronic; Renin-Angiotensin System; Resveratrol; Superoxide Dismutase | 2018 |
Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway.
Topics: Animals; Fibrosis; Humans; Mice; Rats; Renal Insufficiency, Chronic; Resveratrol; Signal Transduction; Sirtuin 1; Smad3 Protein; Stilbenes; Transforming Growth Factor beta1 | 2014 |
Possible role of nitric oxide in the protective effect of resveratrol in 5/6th nephrectomized rats.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood Pressure; Body Weight; Disease Models, Animal; Eating; Enzyme Inhibitors; Kidney Function Tests; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Proteinuria; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Resveratrol; Stilbenes; Survival Rate | 2006 |